OpenLegislation

The National Health Service (Pharmaceutical Services) (Wales) (Miscellaneous Amendments) Regulations 2026

W.S.I. 2026/92 · Made 23 March 2026

Original text. legislation.gov.uk does not revise statutory instruments, so later amendments are not shown here. Changes made to it are listed under each provision when known.

national health service, wales

Made 23 March 2026

Coming into force 2 June 2026

The Welsh Ministers, in exercise of the powers conferred by sections 15, 80 and 203(9) and (10) of the National Health Service (Wales) Act 2006f1, make the following Regulations.

Annotations to the whole text

Footnotes

f1

2006 c. 42.

Contents

  1. 1Title and coming into force
  2. 2Amendment of the National Health Service (Pharmaceutical Services) (Wales) Regulations 2020
  3. Signature
  4. Explanatory note

1Title and coming into force

(1)

The title of these Regulations is the National Health Service (Pharmaceutical Services) (Wales) (Miscellaneous Amendments) Regulations 2026.

(2)

These Regulations come into force on 2 June 2026.

2Amendment of the National Health Service (Pharmaceutical Services) (Wales) Regulations 2020

(1)

The National Health Service (Pharmaceutical Services) (Wales) Regulations 2020f1 are amended as follows.

(2)

In regulation 2f2 (interpretation), in paragraph (1), in the definition of “Electronic Prescription Service”, for “Digital Health and Care Wales” substitute “NHS England”.

(3)

Schedule 5 (terms of service for NHS pharmacists who provide pharmaceutical services in particular by the provisions of drugs) is amended as follows—

(a)

in paragraph 4 (dispensing services), in the Welsh language text—

(i)

after “gyfarpar”, for “offthalmig rhestredig” substitute “rhestredig offthalmig”, and

(ii)

after “feddyginiaeth”, for “offthalmig restredig” substitute “restredig offthalmig”,

(b)

in the heading of paragraph 5Af3 (dispensing ophthalmic listed appliances and ophthalmic listed medicines ordered by qualifying optometrists), in the Welsh language text—

(i)

after “cyfarpar”, for “offthalmig rhestredig” substitute “rhestredig offthalmig”, and

(ii)

after “meddyginiaethau”, for “offthalmig rhestredig” substitute “rhestredig offthalmig”,

(c)

in paragraph 5A(1), in the Welsh language text—

(i)

after “gyfarpar”, for “offthalmig rhestredig” substitute “rhestredig offthalmig”, and

(ii)

after “feddyginiaeth”, for “offthalmig rhestredig” substitute “restredig offthalmig”,

(d)

in paragraph 5A(3), in the Welsh language text—

(i)

after “gyfarpar”, for “offthalmig rhestredig” substitute “rhestredig offthalmig”, and

(ii)

after “feddyginiaeth”, for “offthalmig rhestredig” substitute “restredig offthalmig”,

(e)

in paragraph 5A, omit sub-paragraphs (4) and (5),

(f)

in paragraph 7(2)(b)(ii) (urgent supply without a prescription), for “ETP service” substitute “Electronic Prescription Service”,

(g)

in paragraph 9f4 (providing ordered drugs or appliances), omit sub-paragraphs (2) and (3), and

(h)

after paragraph 39 (Welsh language) insert—

“Workforce reporting

40
(1)

An NHS pharmacist must provide such workforce data to the Local Health Board in whose pharmaceutical list the NHS pharmacist is included as the Local Health Board may from time to time require in connection with its functions.

(2)

The workforce data must be recorded and submitted at such intervals during the financial year as are notified to the NHS pharmacist by the Local Health Board.

(3)

For the purposes of this paragraph, “workforce data” means data, in the form and manner as required by the Local Health Board, relating to individuals engaged to provide pharmaceutical services by the NHS pharmacist.”

(4)

Schedule 6 (terms of service for NHS appliance contractors who provide pharmaceutical services only by the provision of appliances) is amended as follows—

(a)

in paragraph 4(2)(b) (dispensing of appliances), for “ETP service” substitute “Electronic Prescription Service”,

(b)

in paragraph 6(2)(b) (urgent supply without a prescription), for “ETP service” substitute “Electronic Prescription Service”, and

(c)

in paragraph 7(3)(c) (preliminary matters before providing appliances), for “ETP service” substitute “Electronic Prescription Service”.

Signature

Jeremy Miles

Cabinet Secretary for Health and Social Care, one of the Welsh Ministers

23 March 2026

Explanatory note

(This note is not part of the Regulations)

The National Health Service (Pharmaceutical Services) (Wales) Regulations 2020 (S.I. 2020/1073 (W. 241)) (“the 2020 Regulations”) govern the provision of pharmaceutical services as part of the National Health Service in Wales under Part 7 of the National Health Service (Wales) Act 2006 (c. 42).

These Regulations make amendments to the 2020 Regulations in relation to the terms of service for NHS pharmacists who provide pharmaceutical services, in particular to provide for the removal of certain supervision requirements to align with the Human Medicines Regulations 2012 (S.I. 2012/1916) and the Medicines Act 1968 (c. 67) (regulation 2(3)(e) and (g)) and set out a new requirement for the provision of workforce information to Local Health Boards (regulation 2(3)(h)).

These Regulations also make amendments to the 2020 Regulations to correct errors of a technical nature (regulation 2(2), (3)(a) to (d), (3)(f) and (4)).

The Welsh Ministers’ Code of Practice on the carrying out of Regulatory Impact Assessments was considered in relation to these Regulations. As a result, a regulatory impact assessment has been prepared as to the likely costs and benefits of complying with these Regulations. A copy can be obtained from the Welsh Government, Cathays Park, Cardiff, CF10 3NQ and on the website at https://www.gov.wales.